Literature DB >> 35649102

Machine Learning Prediction of Progression in Forced Expiratory Volume in 1 Second in the COPDGene® Study.

Adel Boueiz1,2, Zhonghui Xu1, Yale Chang3, Aria Masoomi3, Andrew Gregory1, Sharon M Lutz4, Dandi Qiao1, James D Crapo5, Jennifer G Dy3, Edwin K Silverman1,2, Peter J Castaldi1,6.   

Abstract

Background: The heterogeneous nature of chronic obstructive pulmonary disease (COPD) complicates the identification of the predictors of disease progression. We aimed to improve the prediction of disease progression in COPD by using machine learning and incorporating a rich dataset of phenotypic features.
Methods: We included 4496 smokers with available data from their enrollment and 5-year follow-up visits in the COPD Genetic Epidemiology (COPDGene®) study. We constructed linear regression (LR) and supervised random forest models to predict 5-year progression in forced expiratory in 1 second (FEV1) from 46 baseline features. Using cross-validation, we randomly partitioned participants into training and testing samples. We also validated the results in the COPDGene 10-year follow-up visit.
Results: Predicting the change in FEV1 over time is more challenging than simply predicting the future absolute FEV1 level. For random forest, R-squared was 0.15 and the area under the receiver operator characteristic (ROC) curves for the prediction of participants in the top quartile of observed progression was 0.71 (testing) and respectively, 0.10 and 0.70 (validation). Random forest provided slightly better performance than LR. The accuracy was best for Global initiative for chronic Obstructive Lung Disease (GOLD) grades 1-2 participants, and it was harder to achieve accurate prediction in advanced stages of the disease. Predictive variables differed in their relative importance as well as for the predictions by GOLD.
Conclusion: Random forest, along with deep phenotyping, predicts FEV1 progression with reasonable accuracy. There is significant room for improvement in future models. This prediction model facilitates the identification of smokers at increased risk for rapid disease progression. Such findings may be useful in the selection of patient populations for targeted clinical trials. JCOPDF
© 2022.

Entities:  

Keywords:  5-year changes in FEV1; copd; disease progression; prediction; random forest machine learning

Year:  2022        PMID: 35649102      PMCID: PMC9448009          DOI: 10.15326/jcopdf.2021.0275

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  36 in total

1.  Random forest: a classification and regression tool for compound classification and QSAR modeling.

Authors:  Vladimir Svetnik; Andy Liaw; Christopher Tong; J Christopher Culberson; Robert P Sheridan; Bradley P Feuston
Journal:  J Chem Inf Comput Sci       Date:  2003 Nov-Dec

2.  The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.

Authors:  Ciro Casanova; Juan P de Torres; Armando Aguirre-Jaíme; Victor Pinto-Plata; Jose M Marin; Elizabeth Cordoba; Rebeca Baz; Claudia Cote; Bartolome R Celli
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

3.  Deaths: Leading Causes for 2018.

Authors:  Melonie Heron
Journal:  Natl Vital Stat Rep       Date:  2021-05

4.  Prediction of chronic obstructive pulmonary disease (COPD) in asthma patients using electronic medical records.

Authors:  Blanca E Himes; Yi Dai; Isaac S Kohane; Scott T Weiss; Marco F Ramoni
Journal:  J Am Med Inform Assoc       Date:  2009-03-04       Impact factor: 4.497

5.  Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Authors:  MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

6.  Computed tomography-quantified emphysema distribution is associated with lung function decline.

Authors:  Firdaus A A Mohamed Hoesein; Eva van Rikxoort; Bram van Ginneken; Pim A de Jong; Mathias Prokop; Jan-Willem J Lammers; Pieter Zanen
Journal:  Eur Respir J       Date:  2012-02-09       Impact factor: 16.671

7.  Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.

Authors:  Surya P Bhatt; Xavier Soler; Xin Wang; Susan Murray; Antonio R Anzueto; Terri H Beaty; Aladin M Boriek; Richard Casaburi; Gerard J Criner; Alejandro A Diaz; Mark T Dransfield; Douglas Curran-Everett; Craig J Galbán; Eric A Hoffman; James C Hogg; Ella A Kazerooni; Victor Kim; Gregory L Kinney; Amir Lagstein; David A Lynch; Barry J Make; Fernando J Martinez; Joe W Ramsdell; Rishindra Reddy; Brian D Ross; Harry B Rossiter; Robert M Steiner; Matthew J Strand; Edwin J R van Beek; Emily S Wan; George R Washko; J Michael Wells; Chris H Wendt; Robert A Wise; Edwin K Silverman; James D Crapo; Russell P Bowler; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2016-07-15       Impact factor: 21.405

8.  Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD.

Authors:  Daniel Kotz; Colin R Simpson; Wolfgang Viechtbauer; Onno C P van Schayck; Aziz Sheikh
Journal:  NPJ Prim Care Respir Med       Date:  2014-05-20       Impact factor: 2.871

9.  Conditional variable importance for random forests.

Authors:  Carolin Strobl; Anne-Laure Boulesteix; Thomas Kneib; Thomas Augustin; Achim Zeileis
Journal:  BMC Bioinformatics       Date:  2008-07-11       Impact factor: 3.169

View more
  1 in total

1.  Predicting COPD Progression in Current and Former Smokers Using a Joint Model for Forced Expiratory Volume in 1 Second and Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio.

Authors:  Matthew Strand; Aastha Khatiwada; David Baraghoshi; David Lynch; Edwin K Silverman; Surya P Bhatt; Erin Austin; Elizabeth A Regan; Aladin M Boriek; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.